A REVIEW OF NHà CáI CK8

Our data present that CK18 is consistently expressed in a variety of epithelial cancers, Specially adenocarcinomas. both of those loss of CK18 expression in cancers derived from CK18 optimistic precursor cells and neo-expression in malignancies derived from CK18 beneficial precursors are typically linked to unfavorable tumor phenotype and disorder